Search

Displaying results 5051 - 5060 of 10000 in total
  1. Drug

    Zankiren

    go.drugbank.com/drugs/DB20787
    Experimental

    The usage of the INN stem '-kiren' in the name indicates that Zankiren is a renin inhibitor. Zankiren has a monoisotopic molecular weight of 705.36 Da.

  2. Drug

    Dibusadol

    go.drugbank.com/drugs/DB21013
    Experimental

    The usage of the INN stem '-adol/-adol-' in the name indicates that Dibusadol is a analgesic. Dibusadol has a monoisotopic molecular weight of 306.19 Da.

  3. Drug

    Mezepine

    go.drugbank.com/drugs/DB21047
    Experimental

    The usage of the INN stem '-zepine' in the name indicates that Mezepine is a tricyclic compound. Mezepine has a monoisotopic molecular weight of 266.18 Da.

  4. Drug

    Etarotene

    go.drugbank.com/drugs/DB21071
    Experimental

    The usage of the INN stem '-arotene' in the name indicates that Etarotene is a arotinoid derivative. Etarotene has a monoisotopic molecular weight of 396.21 Da.

  5. Drug

    Pinolcaine

    go.drugbank.com/drugs/DB21159
    Experimental

    The usage of the INN stem '-caine' in the name indicates that Pinolcaine is a local anaesthetic. Pinolcaine has a monoisotopic molecular weight of 351.22 Da.

  6. Drug

    Lorcinadol

    go.drugbank.com/drugs/DB21160
    Experimental

    The usage of the INN stem '-adol/-adol-' in the name indicates that Lorcinadol is a analgesic. Lorcinadol has a monoisotopic molecular weight of 314.13 Da.

  7. Drug

    Linarotene

    go.drugbank.com/drugs/DB21165
    Experimental

    The usage of the INN stem '-arotene' in the name indicates that Linarotene is a arotinoid derivative. Linarotene has a monoisotopic molecular weight of 398.2 Da.

  8. Drug

    Anetumab ravtansine

    go.drugbank.com/drugs/DB14809
    Investigational

    Anetumab ravtansine is under investigation in clinical trial NCT03455556 (Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer).

    Synonyms: Anti-mesothelin antibody-drug conjugate BAY 94-9343
  9. Drug

    Quaratusugene ozeplasmid

    go.drugbank.com/drugs/DB19231
    Investigational

    Quaratusugene ozeplasmid is under investigation in clinical trial NCT05062980 (Quaratusugene Ozeplasmid (Reqorsa) in Combination With Pembrolizumab in Previously Treated Non-small Lung Cancer).

  10. Drug

    Ethaselen

    go.drugbank.com/drugs/DB15051
    Investigational

    Ethaselen is under investigation in clinical trial NCT02166242 (Ethaselen for the Treatment of Thioredoxin Reductase High Expression Advanced Non-small Cell Lung Cancers).